On May 10, 2011, Albemarle Corporation expanded its presence in the biofuels market by acquiring Catilin Inc., a technology leader in the development and application of heterogeneous biodiesel catalysis.

Catilin’s technology and existing product line will further strengthen Albemarle’s offerings for the renewable fuels market. With the acquisition, Albemarle will now have an expanded catalyst product portfolio, consisting of both Catilin’s ‘T-300’ alongside our ‘TS-15,’ to offer to the fast growing fatty acid methyl ester (“FAME”) biodiesel market worldwide. Catilin also adds to our R&D scale capabilities, as well as a semi-works pilot plant located in Nevada, Iowa.

For more information on Catilin, please email us at catmaster@albemarle.com or visit our expanded biofuels portfolio webpage.